SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $96,000 | -5.0% | 1,827 | -2.1% | 0.00% | 0.0% |
| Q3 2016 | $101,000 | +188.6% | 1,866 | +114.0% | 0.00% | +200.0% |
| Q2 2016 | $35,000 | +59.1% | 872 | +39.5% | 0.00% | 0.0% |
| Q1 2016 | $22,000 | -8.3% | 625 | +17.9% | 0.00% | 0.0% |
| Q4 2015 | $24,000 | +84.6% | 530 | +60.6% | 0.00% | 0.0% |
| Q3 2015 | $13,000 | -18.8% | 330 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $16,000 | +1500.0% | 330 | +1000.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 30 | -50.0% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 60 | +100.0% | 0.00% | – |
| Q4 2013 | $1,000 | -80.0% | 30 | -73.7% | 0.00% | -100.0% |
| Q3 2013 | $5,000 | +25.0% | 114 | -4.2% | 0.00% | 0.0% |
| Q2 2013 | $4,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
| Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
| Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
| Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
| EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
| Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
| Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
| CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
| JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |